SILO PHARMA, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
SILO PHARMA, INC. (SILO) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $33.18 thousand for the 12-month period ending 2025-12-31, per its POS AM filed 2026-04-14.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-04-14
- SILO PHARMA, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $29.51K, a 77.98% decline from fiscal 2022.
- SILO PHARMA, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $133.99K.
- SILO PHARMA, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2021 was -$20.89K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|
| 2025-12-31 | $33.18K POS AM · filed 2026-04-14 |
| 2024-12-31 | $2.33K POS AM · filed 2026-04-14 |
| 2023-12-31 | $29.51K 10-K · filed 2025-03-28 |
| 2022-12-31 | $133.99K 10-K · filed 2024-03-25 |
| 2021-12-31 | -$20.89K 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |